Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
9.57
-0.14 (-1.44%)
At close: Jul 26, 2024, 3:59 PM
9.40
-0.17 (-1.78%)
After-hours: Jul 26, 2024, 6:22 PM EDT
Guardion Health Sciences Revenue
Guardion Health Sciences had revenue of $3.00M in the quarter ending March 31, 2024, a decrease of -5.84%. This brings the company's revenue in the last twelve months to $12.06M, up 1.79% year-over-year. In the year 2023, Guardion Health Sciences had annual revenue of $12.25M with 10.85% growth.
Revenue (ttm)
$12.06M
Revenue Growth
+1.79%
P/S Ratio
1.02
Revenue / Employee
$1,340,279
Employees
9
Market Cap
12.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.25M | 1.20M | 10.85% |
Dec 31, 2022 | 11.05M | 3.82M | 52.77% |
Dec 31, 2021 | 7.23M | 5.34M | 282.74% |
Dec 31, 2020 | 1.89M | 986.91K | 109.30% |
Dec 31, 2019 | 902.94K | -39.22K | -4.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
STRATA Skin Sciences | 32.55M |
Psychemedics | 21.60M |
Novo Integrated Sciences | 13.52M |
Addex Therapeutics | 1.57M |
Lumos Pharma | 1.53M |
Avalo Therapeutics | 1.45M |
Inhibikase Therapeutics | 195.98K |
GHSI News
- 2 months ago - Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution - GlobeNewsWire
- 2 months ago - Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business - GlobeNewsWire
- 2 months ago - Guardion Health Sciences Announces - GlobeNewsWire
- 4 months ago - Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 - GlobeNewsWire
- 6 months ago - What made Guardion Health stock double on Wednesday? - Invezz
- 6 months ago - Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor's Best Inc. - GlobeNewsWire
- 9 months ago - Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 - GlobeNewsWire
- 1 year ago - Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 - GlobeNewsWire